BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Prognosis
3 results:

  • 1. Methylation of PCDH17 and NEFH as prognostic biomarker for nonmetastatic RCC: A cohort study.
    Koudonas A; Papaioannou M; Kampantais S; Anastasiadis A; Hatzimouratidis K; Dimitriadis G
    Medicine (Baltimore); 2022 Jul; 101(28):e29599. PubMed ID: 35838992
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
    Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
    Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. fhit expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
    Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
    J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.